logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Quantum Stocks Surge as Nvidia Once Again Lends a Hand

Decoding the 2026 Market Leaders: 6 Stocks That Have Already Doubled

Mar 2, 2026

Energy, Life Science, Technology

Flu Season Fades, Abbott Stumbles: Is the 54-Year Dividend King Still Worth the Crown?

Teva’s Earnings Beat, Stock Doubles: Buy, Sell, or Hold?

Mar 2, 2026

Life Science

Eli Lilly Soars, Regencell Speculates, but Pfizer's 6.4% Yield Makes It the Real Value Play

Eli Lilly Soars, Regencell Speculates, but Pfizer’s 6.4% Yield Makes It the Real Value Play

Mar 1, 2026

Life Science

到2030年,这些股票可能是表现最佳的生物科技股

Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse

Feb 26, 2026

Life Science

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Feb 26, 2026

Life Science

Germany Drone Bet Puts RHM GY, HAG GY in Focus

Feb 26, 2026

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Following Billionaire Laffont? Analyzing the Investment Thesis for Moderna

Feb 25, 2026

Life Science

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Feb 25, 2026

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy

Feb 24, 2026

Life Science

Medicines Made for Life. | Aytu BioPharma (Nasdaq: AYTU)

Feb 24, 2026

Life Science

IBM Shares Plunge 23%: Is the Century-Old Giant Losing Steam?

Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial

Feb 23, 2026

Life Science

Germany’s Ifo Upswing Puts Asia’s Cycles in Play

Feb 23, 2026

Life Science

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Feb 22, 2026

Life Science

Andrew Arrest Tests UKX, GBP as Palace Crisis Deepens

Feb 20, 2026

Life Science

硅谷权力更迭,Alphabet凭AI强势回归

Searching for the Next ‘Star Stock’? Wall Street Recommends These Two Biotech Stocks

Feb 19, 2026

Life Science

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Feb 19, 2026

Life Science

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

Feb 18, 2026

Life Science

年末压轴布局:两大高增长赛道龙头蓄势待发

A Once-in-a-Decade Buying Opportunity Emerges! Three Stocks Not to Be Missed

Feb 18, 2026

Life Science

  • ‹‹ Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada